4 Quick Covered Call Trades For Option Expiration Week

Includes: AXLL, BSX, GES, MMR
by: Mitchell Harris

Hello folks, its that time of the month again, the last week of the option month, and I have put together four stocks that I feel will give you a nice return for the week and add to our stellar returns for 2012 thus far. Make sure you put some stop losses in as well. Any questions, please feel free. Good luck!

McMoRan Exploration Company (NYSE:MMR) is trading at $13.79 and the March 14 calls are paying you a whopping $.77, which is a 5.6% premium. The extra 21 cents if you get called away is just the cream on top. The stock is a long way from its 52 week high and there is more upside in the next few months. Short position is 18% of the float, and McMoRan also has $3.50 per share in cash so this may be a repeat trade for us, but let us first see how this week goes.

Georgia Gulf Corporation (GGC) is trading at $32.45, so this is a straight premium play. This is another company trading well off of its highs. Georgia Gulf also has a large short position at 13.4%, and 100% of the float is held by institutions. The March $32.50 calls are paying $.85 or 2.6% premium. Not as high as McMoRan, but I like to mix in some conservative plays and some more aggressive ones; 2.6% for a week never hurt anybody.

Guess Corp (NYSE:GES) is going to be an earnings play for the week as well as a straight premium play; I typically throw one of those in there. The company is reporting this Wednesday. Guess has a very strong balance sheet, with $14 million in debt and $430 million in cash. Guess also boasts a 2.2% dividend and it is currently trading at $35.94. The March $36 calls are paying $1.10, a 3.1% premium. I like it, as retail is picking up again, and summer is coming.

Boston Scientific (NYSE:BSX) is my low price pick of the week: At $5.95 it is cheap. The March $6 calls are paying $.11 or 1.8%. Take the extra nickel and you have a 2.7% return for the week. Some 82% of the stock is held by institutions, and shares are also $2 from their 52 week high. Boston Scientific just paid $150 million for Cameron Health to strengthen its cardiac rhythm division, so it is in expansion mode.

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

About this article:

Author payment: $35 + $0.01/page view. Authors of PRO articles receive a minimum guaranteed payment of $150-500. Become a contributor »
Tagged: , Options
Problem with this article? Please tell us. Disagree with this article? .